These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8067099)

  • 21. [Salivary antibodies of Sonnei dysentery reconvalescents and healthy subjects with different probable risks of infection by Shigellae].
    Khazenson LB; Kolesnikova EN; Bogolapova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):43-9. PubMed ID: 7015762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.
    Cohen D; Ashkenazi S; Schneerson R; Farzam N; Bialik A; Meron-Sudai S; Asato V; Goren S; Baran TZ; Muhsen K; Gilbert PB; MacLennan CA
    Clin Microbiol Infect; 2023 Mar; 29(3):366-371. PubMed ID: 36243351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunoglobulin and antibody content in the blood serum, coprofiltrate and saliva of patients with Sonne dysentery].
    Kuz'min SN; Belaia IuA; Kul'berg AIa; Sukhoroslova LI; Mel'nik ZG
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):66-71. PubMed ID: 354289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
    Orr N; Robin G; Cohen D; Arnon R; Lowell GH
    Infect Immun; 1993 Jun; 61(6):2390-5. PubMed ID: 8500877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The excretion of Shigella antigens in persons recovering from dysentery].
    Erkinbekova BK; Karal'nik BV; Aleshin AI; Nurkina NM
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):21-4. PubMed ID: 1455962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for long-term memory of the mucosal immune system: milk secretory immunoglobulin A against Shigella lipopolysaccharides.
    Hayani KC; Guerrero ML; Ruiz-Palacios GM; Gomez HF; Cleary TG
    J Clin Microbiol; 1991 Nov; 29(11):2599-603. PubMed ID: 1774268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New methodological approaches to the use of the PHA reaction in determining anti-Shigella antibodies].
    Kaplin VN; Koriukina IP; Shliapnikova LN; Shalgina LV; Luzina GI; Dvorianskaia SV; Kuznetsov VF; Iurganova GA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):79-83. PubMed ID: 7778383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
    Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
    Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stimulation of the secretory IgA system in monkeys by parenteral immunization with a ribosomal Sonne dysentery vaccine].
    Dzhikidze EK; Stasilevich ZK; Salamatova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):66-70. PubMed ID: 2462772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The significance of the O antigen for the diagnosis of acute Sonne dysentery].
    Ivanov KS; Poliakov SV; Sboĭchakov VB; Semenova IA; Sakal' NN
    Vrach Delo; 1990 May; (5):106-8. PubMed ID: 1697713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
    Cohen D; Green MS; Block C; Rouach T; Ofek I
    J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
    [No Abstract]   [Full Text] [Related]  

  • 32. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.
    Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B
    Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides.
    Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R
    Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function.
    Bernshtein B; Kelly M; Cizmeci D; Zhiteneva JA; Macvicar R; Kamruzzaman M; Bhuiyan TR; Chowdhury F; Khan AI; Qadri F; Charles RC; Xu P; Kováč P; Clarkson KA; Kaminski RW; Alter G; Ryan ET
    Lancet Microbe; 2024 Oct; 5(10):100889. PubMed ID: 39116906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.
    Azim T; Qadri F; Ahmed S; Sarker MS; Halder RC; Hamadani J; Chowdhury A; Wahed MA; Salam MA; Albert MJ
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):701-5. PubMed ID: 8914761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative diagnostic value of methods for detecting dysentery antigens in substrates of the patient's body].
    Li VH; Rubtsov IV; Tregub AV; Remneva TV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):57-61. PubMed ID: 2469267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.
    Ledov VA; Golovina ME; Markina AA; Knirel YA; L'vov VL; Kovalchuk AL; Aparin PG
    Vaccine; 2019 Feb; 37(8):1062-1072. PubMed ID: 30670300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
    Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
    Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.